Chinese General Practice ›› 2025, Vol. 28 ›› Issue (05): 639-648.DOI: 10.12114/j.issn.1007-9572.2024.0295
• Review & Perspectives • Previous Articles
Received:
2024-07-10
Revised:
2024-08-25
Published:
2025-02-15
Online:
2024-11-25
Contact:
LIU Bin
通讯作者:
刘斌
作者简介:
作者贡献:
裴金英提出研究命题,进行文章的构思与撰写;宋金洲、马到丰进行文献的检索与收集;罗孝廷、董晓红、丛树园进行论文修订;刘斌负责文章的质量控制及审校,并对文章整体负责。
基金资助:
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2024.0295
有效成分 | 模型 | 剂量 | 靶点 |
---|---|---|---|
红景天苷 | SAMP8小鼠 | 30 mg/kg | Aβ1-42、铁沉积、MDA、IL-1β、IFN-γ、TNF-α、ACSL4、TFR1↓、GSH、SOD、IL-10、GPX4、SLC7A11、SLC3A2、FTH1、Fpn1、Nrf2、HO-1↑ |
Nrf2基因敲除小鼠、C57BL/6小鼠 | 50 mg/kg | MDA↓、SOD↑、GSH/GSSG↑、GPX4↑、SLC7A11↑、HO-1↑、ROS↓、Nrf2↑、Fe2+↓、PTGS2↓ | |
连翘酯苷A | APP/PS1小鼠 | 30 mg/kg | MDA↓、MMP,Aβ1-42、p-tau、NO↓、IL-4↑、IL-10↑、IL-1β↓、IL-6↓、Fe、GPX4↑、xCT↑、FTL↑、Fpn↑、DRD1↑、CREB↑、BDNF↑、TrkB↑、PI3K、p-AKT、GNAL↑、Adcy5↑、cAMP↑、p-Fyn↓、p-GSK-3β↑、Nrf2↑、TFRC↓、DMT1↓、FTH↑、Iba1↓、GFAP↓、TGF-β↑、MCP-1↓、ALOX5↓、CD33↓、iNOS↓、TNF-α↓、IKK↓ |
芍药苷 | C57BL/6小鼠、APP/PS1小鼠 | 10 mg/kg | Fe3+↓、SOD↑、MDA↓、JC-1↑、P53↓、STAT3、GPX4↑、GAPDH、ΔΨm |
淫羊藿苷 | APP/PS1小鼠、C57BL/6小鼠 | 5、10 mg/kg | MDA↓、SOD↑、MDM2、GSH-Px↑、LDH↓、GSH↑、caspase-3↓、Fe↓、p53↓、Aβ25-35↓、p-Tau |
何首乌苷 | APP/PS1小鼠、C57BL/6小鼠 | 60、120、180 mg/kg | Aβ↓、GSS、SOD1、SOD2、Prdx1、8-OHdG↓、Nrf2↑、Keap1↑、HO-1↑、NQO1↑、GCLC↑、GCLM↑、NLRP3↓、TXNIP↓、TXNRD1↓、iNOS↓、GPX4↑、xCT、GPX4↑、GPX1↑、FTH1↑、xCT↑、CD98↑、DMT1↓、ACSL4↓、NCOA4↓、FTH↓、FTL↓ |
远志皂苷元 | Aβ25-35诱导的PC12细胞 | 15、30、60、120、240 μmol/L | ACSL4↓、PEBP1↓、GPX4↑、ROS↓、MDA、GAPDH |
细叶远志皂苷 | C57BL/6小鼠 | 10 mg/kg | AKT、STAT3、CASP3、BDNF↑、PSD95↑、p-TrkB↑、Actin、p-Akt↑、mRNA↑、Ca2+↓、m-calpain↓、calpastatin↑、MDA↓、GSH↑、SOD↑、CAT↑、ROS↓、MFI↓、ACSL4↓、GPX4↑、SLC7A11↑、SYN |
银杏内酯B | SAMR1小鼠、SAMP8小鼠 | 20、30、40 mg/kg | GFAP、Iba-1、TNF-a、IL-1b、IL-6、SOD↑、GSH↑、MDA↓、NO↓、ROS↓、GPX4↑、Fe2+↓、TFR1、NCOA4、FTH1↑、Nrf2↑、RSL3、GAPDH、Lamin B1、DAPI |
Aβ1-42诱导的N2a细胞 | 100 μmol/L | FTH1↑、SPP1↓、ROS↓、SOD↑、MDA↓、SLC7A11↓、Psen2、Fn1↑、Ftl1↑、Syn1↓、Apom↓ | |
小檗碱 | 3×Tg-AD小鼠、WT小鼠 | 50 mg/kg | APP↓、Bace1↓、Aβ1-42↓、ADAM10↑、P-tau↓、Fe3+、Fe2+、FTH1、TFR、GSH↑、MDA↓、GPX4↑、SLC7A11↑、ACSL4↓、Nrf2、Keap1、4HNE↓、Fpn1、 |
番泻苷A | C57BL/6小鼠、APP/PS1小鼠 | 7.5、15、30 mg/kg | caspase-3↓、PARP-1↓、GSH↑、MDA↓、ROS、IL-1β↓、IL-6↓、TNF-α↓、TRAF6↓、p-P65↓ |
旋覆花内酯 | 5xFAD小鼠、C57BL6小鼠 | 20 mg/kg | TNF-α↓、PGE2↓、IL-10↑、Arg-1↑、iNOS↓、COX-2↓、GPx4、GSH↑、MDA↓、T-SOD↓、BACE1↓、Aβ↓、p-Tau↓、GFAP↓、Iba-1↓ |
圣草酚 | APP/PS1小鼠 | 50 mg/kg | Aβ↓、p-Tau↓、TfRC↓、FTH↓、Fpn↑、MDA↓、GPX4↑、ROS、mRNA↑、p-Nrf2↑、VDR、HO-1↑ |
表没食子儿茶素没食子酸酯 | DNL细胞、CHO细胞 | 1~10 μmol/L | TfR↑、β-actin、Aβ↓、holo-APP↓、IRPs、APP、sAPPα↑、mRNA |
仙茅苷 | ICR小鼠 | 50、100 mg/kg | GPX4↑、SLC7A11↓、MDA↓、Fe↓、GSH↑、GSH/GSSG↑、GAPDH、GCLM↑、GCLC↑、ROS↓、LIP、Aβ1-42↓、ACSL4↓、p-BECN1↑、p-Tau↓、FPN↑、STEAP3、DMT1 |
大黄酚 | SD大鼠(D-半乳糖造模) | 0.036 mg/mL | GPx↑、GSH↑、GPX4↑、ROS↓、GAPDH、Aβ |
麝香水提物 | HT22细胞 | 330 μg/mL、60 μg/mL | MDA↓、GSH↑、ROS↓、GPX4↑、SLC7A11↑、TFRC↓、Fpn1↑、FTH1↑、Fe2+、Nrf2、Keap1↓、HO-1、FTH1 |
茯苓酸 | SD大鼠(Aβ25-35诱导) | 50 mg/kg | Nrf2、SLC7A11、GPX4↑、GSH↑、MDA↓、Fe2+↓ |
Table 1 Experimental study on the treatment of Alzheimer's disease with effective ingredients of traditional Chinese medicine
有效成分 | 模型 | 剂量 | 靶点 |
---|---|---|---|
红景天苷 | SAMP8小鼠 | 30 mg/kg | Aβ1-42、铁沉积、MDA、IL-1β、IFN-γ、TNF-α、ACSL4、TFR1↓、GSH、SOD、IL-10、GPX4、SLC7A11、SLC3A2、FTH1、Fpn1、Nrf2、HO-1↑ |
Nrf2基因敲除小鼠、C57BL/6小鼠 | 50 mg/kg | MDA↓、SOD↑、GSH/GSSG↑、GPX4↑、SLC7A11↑、HO-1↑、ROS↓、Nrf2↑、Fe2+↓、PTGS2↓ | |
连翘酯苷A | APP/PS1小鼠 | 30 mg/kg | MDA↓、MMP,Aβ1-42、p-tau、NO↓、IL-4↑、IL-10↑、IL-1β↓、IL-6↓、Fe、GPX4↑、xCT↑、FTL↑、Fpn↑、DRD1↑、CREB↑、BDNF↑、TrkB↑、PI3K、p-AKT、GNAL↑、Adcy5↑、cAMP↑、p-Fyn↓、p-GSK-3β↑、Nrf2↑、TFRC↓、DMT1↓、FTH↑、Iba1↓、GFAP↓、TGF-β↑、MCP-1↓、ALOX5↓、CD33↓、iNOS↓、TNF-α↓、IKK↓ |
芍药苷 | C57BL/6小鼠、APP/PS1小鼠 | 10 mg/kg | Fe3+↓、SOD↑、MDA↓、JC-1↑、P53↓、STAT3、GPX4↑、GAPDH、ΔΨm |
淫羊藿苷 | APP/PS1小鼠、C57BL/6小鼠 | 5、10 mg/kg | MDA↓、SOD↑、MDM2、GSH-Px↑、LDH↓、GSH↑、caspase-3↓、Fe↓、p53↓、Aβ25-35↓、p-Tau |
何首乌苷 | APP/PS1小鼠、C57BL/6小鼠 | 60、120、180 mg/kg | Aβ↓、GSS、SOD1、SOD2、Prdx1、8-OHdG↓、Nrf2↑、Keap1↑、HO-1↑、NQO1↑、GCLC↑、GCLM↑、NLRP3↓、TXNIP↓、TXNRD1↓、iNOS↓、GPX4↑、xCT、GPX4↑、GPX1↑、FTH1↑、xCT↑、CD98↑、DMT1↓、ACSL4↓、NCOA4↓、FTH↓、FTL↓ |
远志皂苷元 | Aβ25-35诱导的PC12细胞 | 15、30、60、120、240 μmol/L | ACSL4↓、PEBP1↓、GPX4↑、ROS↓、MDA、GAPDH |
细叶远志皂苷 | C57BL/6小鼠 | 10 mg/kg | AKT、STAT3、CASP3、BDNF↑、PSD95↑、p-TrkB↑、Actin、p-Akt↑、mRNA↑、Ca2+↓、m-calpain↓、calpastatin↑、MDA↓、GSH↑、SOD↑、CAT↑、ROS↓、MFI↓、ACSL4↓、GPX4↑、SLC7A11↑、SYN |
银杏内酯B | SAMR1小鼠、SAMP8小鼠 | 20、30、40 mg/kg | GFAP、Iba-1、TNF-a、IL-1b、IL-6、SOD↑、GSH↑、MDA↓、NO↓、ROS↓、GPX4↑、Fe2+↓、TFR1、NCOA4、FTH1↑、Nrf2↑、RSL3、GAPDH、Lamin B1、DAPI |
Aβ1-42诱导的N2a细胞 | 100 μmol/L | FTH1↑、SPP1↓、ROS↓、SOD↑、MDA↓、SLC7A11↓、Psen2、Fn1↑、Ftl1↑、Syn1↓、Apom↓ | |
小檗碱 | 3×Tg-AD小鼠、WT小鼠 | 50 mg/kg | APP↓、Bace1↓、Aβ1-42↓、ADAM10↑、P-tau↓、Fe3+、Fe2+、FTH1、TFR、GSH↑、MDA↓、GPX4↑、SLC7A11↑、ACSL4↓、Nrf2、Keap1、4HNE↓、Fpn1、 |
番泻苷A | C57BL/6小鼠、APP/PS1小鼠 | 7.5、15、30 mg/kg | caspase-3↓、PARP-1↓、GSH↑、MDA↓、ROS、IL-1β↓、IL-6↓、TNF-α↓、TRAF6↓、p-P65↓ |
旋覆花内酯 | 5xFAD小鼠、C57BL6小鼠 | 20 mg/kg | TNF-α↓、PGE2↓、IL-10↑、Arg-1↑、iNOS↓、COX-2↓、GPx4、GSH↑、MDA↓、T-SOD↓、BACE1↓、Aβ↓、p-Tau↓、GFAP↓、Iba-1↓ |
圣草酚 | APP/PS1小鼠 | 50 mg/kg | Aβ↓、p-Tau↓、TfRC↓、FTH↓、Fpn↑、MDA↓、GPX4↑、ROS、mRNA↑、p-Nrf2↑、VDR、HO-1↑ |
表没食子儿茶素没食子酸酯 | DNL细胞、CHO细胞 | 1~10 μmol/L | TfR↑、β-actin、Aβ↓、holo-APP↓、IRPs、APP、sAPPα↑、mRNA |
仙茅苷 | ICR小鼠 | 50、100 mg/kg | GPX4↑、SLC7A11↓、MDA↓、Fe↓、GSH↑、GSH/GSSG↑、GAPDH、GCLM↑、GCLC↑、ROS↓、LIP、Aβ1-42↓、ACSL4↓、p-BECN1↑、p-Tau↓、FPN↑、STEAP3、DMT1 |
大黄酚 | SD大鼠(D-半乳糖造模) | 0.036 mg/mL | GPx↑、GSH↑、GPX4↑、ROS↓、GAPDH、Aβ |
麝香水提物 | HT22细胞 | 330 μg/mL、60 μg/mL | MDA↓、GSH↑、ROS↓、GPX4↑、SLC7A11↑、TFRC↓、Fpn1↑、FTH1↑、Fe2+、Nrf2、Keap1↓、HO-1、FTH1 |
茯苓酸 | SD大鼠(Aβ25-35诱导) | 50 mg/kg | Nrf2、SLC7A11、GPX4↑、GSH↑、MDA↓、Fe2+↓ |
[1] |
|
[2] |
|
[3] |
|
[4] |
|
[5] |
|
[6] |
李燕新,吕占云,李维,等. 铁死亡相关蛋白在AD小鼠海马中的表达[J]. 中国神经精神疾病杂志,2018,44(12):727-731. DOI:10.3969/j.issn.1002-0152.2018.12.008.
|
[7] |
|
[8] |
|
[9] |
|
[10] |
|
[11] |
|
[12] |
|
[13] |
|
[14] |
|
[15] |
|
[16] |
|
[17] |
|
[18] |
|
[19] |
|
[20] |
|
[21] |
|
[22] |
|
[23] |
|
[24] |
|
[25] |
|
[26] |
|
[27] |
|
[28] |
|
[29] |
|
[30] |
|
[31] |
|
[32] |
|
[33] |
|
[34] |
|
[35] |
|
[36] |
|
[37] |
|
[38] |
|
[39] |
|
[40] |
|
[41] |
|
[42] |
|
[43] |
|
[44] |
|
[45] |
|
[46] |
|
[47] |
|
[48] |
|
[49] |
|
[50] |
|
[51] |
|
[52] |
|
[53] |
|
[54] |
|
[55] |
|
[56] |
|
[57] |
|
[58] |
|
[59] |
|
[60] |
|
[61] |
|
[62] |
|
[63] |
|
[64] |
|
[65] |
|
[66] |
|
[67] |
|
[68] |
|
[69] |
|
[70] |
|
[71] |
|
[72] |
|
[73] |
|
[74] |
|
[75] |
|
[76] |
|
[77] |
|
[78] |
樊赟,窦润鹏,胡久略,等. 茯苓酸通过Nrf2/SLC7A11/GPX4信号通路调控铁死亡改善阿尔茨海默病大鼠认知障碍的研究[J]. 中国全科医学,2024,27(2):177-183. DOI:10.12114/j.issn.1007-9572.2023.0326.
|
[79] |
|
[80] |
刘珊,贺小平,赵炎,等. 淫黄葛合剂对APP/PS1 HAMP-/-小鼠认知功能和铁死亡氨基酸代谢通路的影响[J]. 中国病理生理杂志,2024,40(3):502-510. DOI:10.3969/j.issn.1000-4718.2024.03.014.
|
[81] |
|
[1] | ZHANG Tianyang, XU Wenxiu, QIN Xinyu, XING Xuexue, BI Meirong. Research Progress on the Mechanism of Ferroptosis in Neonatal Hypoxic-ischemic Brain Damage [J]. Chinese General Practice, 2025, 28(06): 666-672. |
[2] | YUAN Yiqing, CHEN Honglin. Research Progress on Stigma of Cognitive Disorders [J]. Chinese General Practice, 2025, 28(05): 631-638. |
[3] | DU Huijie, LIU Xingyu, XU Minghuan, YANG Xuezhi, ZHANG Huiqin, MO Jiali, LU Yi, KUANG Jie. Advances in the Prognostic Prediction of Acute Ischemic Stroke: Using Machine Learning Predictive Models as an Example [J]. Chinese General Practice, 2025, 28(05): 554-560. |
[4] | Phillips William R., Sturgiss Elizabeth, Glasziou Paul, olde Hartman Tim C., Orkin Aaron M., Prathivadi Pallavi, Reeve Joanne, Russell Grant M., van Weel Chris. Improving the Reporting of Primary Care Research: Consensus Reporting Items for Studies in Primary Care—the CRISP Statement [J]. Chinese General Practice, 2025, 28(04): 385-392. |
[5] | JIANG Shen, WU Jing, ZHOU Jiali, JIANG Denan, SUN Weidi, CHENG Siqing, ZHU Siyu, HOU Leying, SONG Peige. Progress in the Study of the Association between Adverse Childhood Experiences and the Prevalence of Hypertension in Adulthood [J]. Chinese General Practice, 2025, 28(03): 358-364. |
[6] | XIN Bo, WU Yixin, ZHANG Di, HE Yuxin, YANG Shan, LI Mengchi, JIANG Wenhui. Advances in Cognitive Impairment in the Multimorbidity [J]. Chinese General Practice, 2025, 28(02): 143-148. |
[7] | CHU Hongling, LI Shurun, LI Xinlin, CHEN Yahong. Current Status of Implementation of Patient Involvement in Health Care to Improve Quality of Care among Chronic Obstructive Pulmonary Disease: a Scoping Review [J]. Chinese General Practice, 2025, 28(02): 228-233. |
[8] | PAN Zihan, LI Shurun, CHEN Yahong. Research Progress and Prospects of Internet of Things Technology in Chronic Obstructive Pulmonary Disease Management [J]. Chinese General Practice, 2024, 27(35): 4446-4454. |
[9] | HUANG Kai, ZHANG Yi, YANG Chun, YANG Ling. Advances in Gut Microbiota in Heart Failure Combined with Depression [J]. Chinese General Practice, 2024, 27(35): 4455-4461. |
[10] | GUO Jia, CAO Chunmei, LIU Guochun, ZHENG Man, ZHU Ruihan, LONG Wei. Effects of Different Exercise Types on Sleep in Insomnia Patients: a Network Meta-analysis [J]. Chinese General Practice, 2024, 27(35): 4376-4387. |
[11] | DONG Menglong, LIN Zhifeng, FAN Mengmeng, XUE Shengwen, LIU Yuhang, WANG Yi, CHENG Jinxiang. Advance in Evaluation of the Clinical Efficacy of Non-benzodiazepine Drugs in Treating Comorbid Insomnia and Sleep Apnea [J]. Chinese General Practice, 2024, 27(35): 4388-4396. |
[12] | WANG Yanzhe, LIN Zheng, LI Sha, WANG Qingyu, CHENG Hantian. Research Progress on Sleep Health [J]. Chinese General Practice, 2024, 27(35): 4364-4369. |
[13] | LI Miaomiao, WU Xue, JING Chengyang, ZHANG Le, ZHAO Hui, LIAO Xing. The Application of Rapid Review in the Field of Medical Research: a Bibliometric Analysis [J]. Chinese General Practice, 2024, 27(33): 4215-4224. |
[14] | ZHANG Huimin, SHAN Dawei, ZHANG Yan. Perspectives on the Application of Neural Oscillations in the Diagnosis and Treatment of Consciousness Disorders [J]. Chinese General Practice, 2024, 27(32): 4093-4096. |
[15] | FENG Tianxiao, WANG Xu, BU Hanmei, QIN Xiaokuan, XIAO Xiangyu, WEI Xu, ZHU Liguo. Study on the Evidence Map of Manual Therapy of Clinical Advantageous Diseases in Traditional Chinese Orthopedics [J]. Chinese General Practice, 2024, 27(32): 4021-4028. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||